Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Armitage

Showing results (431-440 of 582) with videos related to

Pageof 59
Sort By:
Cell|May 7, 1993
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factorR G Goodwin, M R Alderson, C A Smith, et al.
Blood|September 1, 1995
Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytesW J Murphy, S Funakoshi, M Beckwith, et al.
Sociology of Health & Illness|September 22, 2020
'So just to go through the options…': patient choice in the telephone delivery of the NHS Improving Access to Psychological Therapies servicesAnnie Irvine, Paul Drew, Peter Bower, et al.
BJGP Open|August 21, 2025
Personalising renal function monitoring and interventions in people living with heart failure: protocol for co-designing a care pathway in the RENAL-HF programmeSuzy C Hargreaves, Christopher J Armitage, Benjamin C Brown, et al.
Nature|September 3, 2025
A prudent planetary limit for geologic carbon storageMatthew J Gidden, Siddharth Joshi, John J Armitage, et al.
European Journal of Immunology|July 1, 1993
Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigensS F Ziegler, F Ramsdell, K A Hjerrild, et al.
Science (New York, N.Y.)|February 12, 1993
CD40 ligand gene defects responsible for X-linked hyper-IgM syndromeR C Allen, R J Armitage, M E Conley, et al.
Nature|May 7, 1992
Molecular and biological characterization of a murine ligand for CD40R J Armitage, W C Fanslow, L Strockbine, et al.
Perspectives on Sexual and Reproductive Health|December 11, 2019
Reproductive Life Planning and Contraceptive Action Planning for Privately Insured Women: The MyNewOptions StudyCynthia H Chuang, Carol S Weisman, Diana L Velott, et al.
Pilot and Feasibility Studies|December 21, 2021
Testing a breast cancer prevention and a multiple disease prevention weight loss programme amongst women within the UK NHS breast screening programme-a randomised feasibility studyMichelle Harvie, David P French, Mary Pegington, et al.
Pageof 59

Showing results (431-440 of 582) with videos related to

Sort By:
Pageof 59
Cell|May 7, 1993
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factorR G Goodwin, M R Alderson, C A Smith, et al.
Blood|September 1, 1995
Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytesW J Murphy, S Funakoshi, M Beckwith, et al.
Sociology of Health & Illness|September 22, 2020
'So just to go through the options…': patient choice in the telephone delivery of the NHS Improving Access to Psychological Therapies servicesAnnie Irvine, Paul Drew, Peter Bower, et al.
BJGP Open|August 21, 2025
Personalising renal function monitoring and interventions in people living with heart failure: protocol for co-designing a care pathway in the RENAL-HF programmeSuzy C Hargreaves, Christopher J Armitage, Benjamin C Brown, et al.
Nature|September 3, 2025
A prudent planetary limit for geologic carbon storageMatthew J Gidden, Siddharth Joshi, John J Armitage, et al.
European Journal of Immunology|July 1, 1993
Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigensS F Ziegler, F Ramsdell, K A Hjerrild, et al.
Science (New York, N.Y.)|February 12, 1993
CD40 ligand gene defects responsible for X-linked hyper-IgM syndromeR C Allen, R J Armitage, M E Conley, et al.
Nature|May 7, 1992
Molecular and biological characterization of a murine ligand for CD40R J Armitage, W C Fanslow, L Strockbine, et al.
Perspectives on Sexual and Reproductive Health|December 11, 2019
Reproductive Life Planning and Contraceptive Action Planning for Privately Insured Women: The MyNewOptions StudyCynthia H Chuang, Carol S Weisman, Diana L Velott, et al.
Pilot and Feasibility Studies|December 21, 2021
Testing a breast cancer prevention and a multiple disease prevention weight loss programme amongst women within the UK NHS breast screening programme-a randomised feasibility studyMichelle Harvie, David P French, Mary Pegington, et al.
Pageof 59